Abstract
The aim of this study was to compare unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT in the detection of hepatic colorectal metastases. Forty-four patients with hepatic colorectal metastases were examined with unenhanced and MnDPDP-enhanced MRI and with unenhanced and contrast-enhanced spiral CT. The MR examination protocol included baseline T1-weighted spin-echo (SE), T1-weighted gradient-recalled-echo (GRE), and T2-weighted fast-SE sequences; and T1-weighted SE and T1-weighted GRE sequences obtained 30–60 min after administration of 0.5 µmol/kg (0.5 ml/kg) mangafodipir trisodium (MnDPDP). Images were interpreted by three blinded readers. Findings at CT and MRI were compared with those at intraoperative US, which were used as term of reference. Intraoperative US detected 128 metastases. In a lesion-by-lesion analysis, the overall detection rate was 71% (91 of 128) for spiral CT, 72% (92 of 128) for unenhanced MRI, and 90% (115 of 128) for MnDPDP-enhanced MRI. MnDPDP-enhanced MRI was more sensitive than either unenhanced MRI (p<0.0001) or spiral CT (p=0.0007). In a patient-by-patient analysis, agreement with gold standard was higher for MnDPDP-enhanced MRI (33 of 44 cases) than for spiral CT (22 of 44 cases, p=0.0023) and unenhanced MRI (21 of 44 cases, p=0.0013). MnDPDP-enhanced MRI is superior to unenhanced MRI and spiral CT in the detection of hepatic colorectal metastases.
Similar content being viewed by others
References
Brand MI, Saclarides TJ, Dobson HD, Millikan KW (2000) Liver resection for colorectal cancer: liver metastases in the aged. Am Surg 66:412–415
Bolton JS, Fuhrman GM (2000) Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 231:743–751
Gillams AR, Lees WR (2000) Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 43:656–6613
Lencioni R, Cioni D, Bartolozzi C (2001) Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 26:345–360
Vogl TJ, Muller PK, Mack MG, Straub R, Engelmann K, Neuhaus P (1999) Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 9:675–846
Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19:59–71
Sugarbaker PH (1990) Surgical decision-making for large bowel cancer metastatic to the liver. Radiology 174:621–626
Mahfouz AE, Hamm B, Mathieu D (1996) Imaging of metastases to the liver. Eur Radiol 6:607–614
Kondo H, Kanematsu M, Hashi H, Murakami T, Kim T, Hori M, Matsuo M, Nakamura H (1999) Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. Am J Roentgenol 174:947–954
Semelka RC, Cance WG, Marcos HB, Mauro MA (1999) Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 213:86–91
Van Beers BE, Gallez B, Pringot J (1997) Contrast-enhanced MR imaging of the liver. Radiology 203:297–306
Bartolozzi C, Lencioni R, Donati F, Cioni D (1999) Abdominal MR: liver and pancreas. Eur Radiol 9:1496–1512
Kane PA, Ayton V, Walters HL, Benjamin I, Heaton ND, Williams R, Karani JB (1997) MnDPDP-enhanced MR imaging of the liver: correlation with surgical findings. Acta Radiol 38:650–654
Clement O, Siauve N, Cuenod CA, Vuillemin-Bodaghi V, Leconte I, Frija G (1999) Mechanisms of action of liver contrast agents: impact for clinical use. J Comput Assist Tomogr 23 (Suppl 1):S45–S52
Coffin CM, Diche T, Mahfouz A, Alexandre M, Caseiro-Alves F, Rahmouni A, Vasile N, Mathieu D (1999) Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 9:444–449
Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R (2000) MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma. Eur Radiol 10:1697–1702
Federle M, Chezmar J, Rubin DL, Weinreb J, Freeny P, Schmiedl UP, Brown JJ, Borrello JA, Lee JK, Semelka RC, Mattrey R, Dachman AH, Saini S, Harms SE, Mitchell DG, Anderson MW, Halford HH III, Bennett WF, Young SW, Rifkin M, Gay SB, Ballerini R, Sherwin PF, Robison RO (2000) Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials. Efficacy of early imaging. J Magn Reson Imaging. 12:689–701
Sahani DV, O'Malley ME, Bhat S, Hahn PF, Saini S (2002) Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results. J Comput Assist Tomogr 26:216–222
Helmberger TK, Laubenberger J, Rummeny E, Jung G, Sievers K, Dohring W, Meurer K, Reiser MF (2002) MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool. Eur Radiol 12:62–70
Soyer P, Levesque M, Elias D, Zeitoun G, Roche A (1992) Detection of liver metastases from colorectal cancer: comparison of intraoperative ultrasound and CTAP. Radiology 183:531–544
Soyer P, Levesque M, Caudron C, Elias D, Zeitoun G, Roche A (1993) MRI of liver metastases from colorectal cancer vs CT during arterial portography. J Comput Assist Tomogr 17:67–74
Peterson MS, Baron RL, Dodd GD III, Zajko AJ, Oliver JH III, Miller WJ, Carr BI, Bron KM, Campbell WL, Sammon JK (1992) Hepatic parenchymal perfusion defects detected with CTAP: imaging–pathologic correlation. Radiology 185:149–155
Lencioni R, Donati F, Cioni D, Paolicchi A, Cicorelli A, Bartolozzi C (1998) Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. MAGMA 7:76–87
Low RN, Francis IR, Sigeti IS, Foo TKF (1993) Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient recalled imaging. Radiology 186:803–811
Semelka RC, Shoenut JP, Ascher SM, Kroeker MA, Greenberg HM, Yaffe CS, Micflikier AB (1994) Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences. J Magn Reson Imaging 4:319–323
Hamm B, Mahfouz AE, Taupitz M, Mitchell DG, Nelson R, Halpern E, Speidel A, Wolf KJ, Saini S (1997) Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? Radiology 202:677–682
Marchal G, van Hecke P, Demaerel P, Decrop E, Kennis C, Baert AL, van der Schueren E (1989) Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. Am J Roentgenol 152:771–775
Denys A, Arrive L, Servois V, Dubray B, Najmark D, Sibert A, Menu Y (1994) Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 193:665–669
Bellin MF, Zaim S, Auberton E, Sarfati G, Duron JJ, Khayat D, Grellet J (1994) Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 193:657–663
Seneterre E, Taourel P, Bouvier Y, Pradel J, van Beers B, Daures JP, Pringot J, Mathieu D, Bruel JM (1996) Detection of hepatic metastases: ferumoxides-enhanced MR imaging vs unenhanced MR imaging and CT during arterial portography. Radiology 200:785–792
Hagspiel KD, Niedl KFW, Eichenberger AC, Weder W, Marincek B (1995) Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 196:471–478
Mann GN, Marx HF, Lai LL, Wagman LD (2001) Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability. Ann Surg Oncol 8:573–579
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bartolozzi, C., Donati, F., Cioni, D. et al. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 14, 14–20 (2004). https://doi.org/10.1007/s00330-003-1966-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-003-1966-9